Ausdal Financial Partners Inc. decreased its stake in Cardinal Health Inc (NYSE:CAH) by 10.2% during the 4th quarter, Holdings Channel reports. The firm owned 15,215 shares of the company’s stock after selling 1,735 shares during the period. Ausdal Financial Partners Inc.’s holdings in Cardinal Health were worth $932,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in CAH. Steward Partners Investment Advisory LLC bought a new stake in Cardinal Health during the 3rd quarter valued at $102,000. Ffcm LLC bought a new stake in Cardinal Health during the 4th quarter valued at $105,000. JNBA Financial Advisors raised its stake in Cardinal Health by 615.4% during the 4th quarter. JNBA Financial Advisors now owns 1,860 shares of the company’s stock valued at $114,000 after acquiring an additional 1,600 shares in the last quarter. Cerebellum GP LLC bought a new stake in Cardinal Health during the 4th quarter valued at $129,000. Finally, Advisory Services Network LLC raised its stake in Cardinal Health by 18.4% during the 2nd quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock valued at $136,000 after acquiring an additional 270 shares in the last quarter. 87.55% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Inc (CAH) opened at $67.34 on Thursday. Cardinal Health Inc has a 1 year low of $54.66 and a 1 year high of $84.88. The stock has a market capitalization of $20,673.10, a price-to-earnings ratio of 11.71, a PEG ratio of 1.42 and a beta of 0.96. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.57 and a current ratio of 1.09.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, February 8th. The company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.17. Cardinal Health had a return on equity of 8.93% and a net margin of 0.45%. The company had revenue of $35.19 billion for the quarter, compared to analysts’ expectations of $34.63 billion. During the same period last year, the firm earned $1.34 EPS. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. sell-side analysts predict that Cardinal Health Inc will post 5.44 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Sunday, April 15th. Stockholders of record on Monday, April 2nd will be given a dividend of $0.4624 per share. This represents a $1.85 annualized dividend and a dividend yield of 2.75%. The ex-dividend date is Thursday, March 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 32.17%.

Cardinal Health declared that its Board of Directors has initiated a share buyback program on Thursday, February 8th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its stock is undervalued.

Several analysts have weighed in on CAH shares. Mizuho set a $70.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Tuesday, October 24th. Jefferies Group cut their target price on Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a research note on Tuesday, November 7th. Zacks Investment Research raised Cardinal Health from a “sell” rating to a “hold” rating in a research note on Wednesday, November 8th. Argus downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, November 15th. Finally, Morgan Stanley downgraded Cardinal Health from an “equal weight” rating to an “underweight” rating in a research note on Monday, November 20th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $75.84.

In other news, CEO Michael C. Kaufmann sold 18,586 shares of Cardinal Health stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $73.90, for a total transaction of $1,373,505.40. Following the transaction, the chief executive officer now directly owns 211,849 shares in the company, valued at approximately $15,655,641.10. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.97% of the stock is currently owned by company insiders.

WARNING: This piece was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/02/15/ausdal-financial-partners-inc-sells-1735-shares-of-cardinal-health-inc-cah.html.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.